FIELD: organic chemistry, chemical-pharmaceutical industry, medicine, pharmacy. SUBSTANCE: invention relates to novel agents used for treatment of erectile function comprising a derivative of 3(2H)-pyridazinone that represents 4-bromo-6-[3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino)-3(2H)-pyridazinone or 4-bromo-6-[3-(4-chlorophenyl)-3-hydroxypropoxy)-5-(3-pyridylmethylamino)-3(2H)-pyridazinone or its pharmaceutically acceptable salt. EFFECT: valuable medicinal properties of agent. 6 dwg, 5 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 3(2H)-PYRIDAZINONE AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION ON THEIR BASE | 1991 |
|
RU2054004C1 |
| AGENT FOR TREATMENT OF SOIL OR SEEDS INCLUDING COMPOUNDS OF QUINOLINE OR THEIR SALTS AS ACTIVE INGREDIENT, OR METHOD TO PREVENT PLANT DISEASES USING THIS AGENT | 2007 |
|
RU2443110C2 |
| 3-ETHYLIDENEHYDRAZINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS | 2005 |
|
RU2395505C2 |
| PYRIDAZINONE DERIVATIVES AND METHODS OR PREPARING THEREOF | 1996 |
|
RU2131419C1 |
| DERIVATIVES OF PYRIDAZINONE AND TRIAZINONE AND THEIR USING AS PHARMACEUTICAL PREPARATIONS | 2001 |
|
RU2279428C2 |
| 3-ALKYLIDENHYDRAZINO-HETEROARYL COMPOUNDS AS ACTIVATORS OF THROMBOPROTEIN RECEPTOR | 2004 |
|
RU2358970C2 |
| DERIVATIVES OF ADAMANTANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2214997C2 |
| COMPOUND OF THIAZOLIDINE OF PYRIDINE TYPE OR ITS SALT, HYPOGLYCAEMIC AGENT, ANTIGLYCATING AGENT AND PHARMACEUTICAL AGENT INHIBITING HYPERGLYCAEMIA, NONENZYMATIC GLYCATION AND ALDOSOREDUCTASE FOR PROPHYLAXIS AND TREATMENT OF DIABETES MELLITUS AND DIABETIC COMPLICATIONS | 1995 |
|
RU2125053C1 |
| NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS | 2007 |
|
RU2398769C2 |
| T-TYPE CALCIUM CHANNEL-BLOCKING AGENT | 2004 |
|
RU2326886C2 |
